Show simple item record

dc.contributor.authorOrsolini, Laura
dc.contributor.authorCorkery, John
dc.contributor.authorPapanti, Duccio
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2017-06-30T13:30:49Z
dc.date.available2017-06-30T13:30:49Z
dc.date.issued2017-06-28
dc.identifier.citationOrsolini , L , Corkery , J , Papanti , D & Schifano , F 2017 , ' From concept(ion) to life after death/the grave: the ‘natural’ history and life-cycle(s) of Novel Psychoactive Substances (NPS) ' , Human Psychopharmacology: Clinical and Experimental , vol. 32 , no. 3 , e2566 . https://doi.org/10.1002/hup.2566
dc.identifier.issn0885-6222
dc.identifier.otherPURE: 11676150
dc.identifier.otherPURE UUID: eecc561d-44aa-4954-9a5a-8e1ab10b0958
dc.identifier.otherScopus: 85021365453
dc.identifier.urihttp://hdl.handle.net/2299/18700
dc.descriptionThis is the peer reviewed version of the following article: John Martin Corkery, Laura Orsolini, Duccio Papanti, and Fabrizio Schifano, 'From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS), Human Psychopharmacology: Clinical and Experimental, Vol. 32 (3), e2566, May 2017, doi: https://doi.org/10.1002/hup.2566. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Copyright © 2017 John Wiley & Sons, Ltd.
dc.description.abstractA range of information needs should be met in order to better understand and predict the longevity/existence of Novel Psychoactive Substances (NPS). This conceptual paper argues that one way of assessing how long a molecule may be around is to document how the lifecycles or natural histories of ‘traditional’ drugs and NPS evolve. The earliest indication of the possible appearance of a new substance might be evidenced on the DeepWeb. However, this means they are less visible, in line with the clandestine nature of drug use and supply. Therefore, monitoring discussion groups/fora needs the development of new methods compared to those used in the Surface Net. Issues needing consideration in establishing NPS life-cycles are outlined here, together with the probable outcomes that could result. The approach advocated means that it should be easier to identify which NPS are likely to come up or are emerging in real time, and, therefore, pre-empt/prevent their supply.en
dc.language.isoeng
dc.relation.ispartofHuman Psychopharmacology: Clinical and Experimental
dc.subjectNovel Psychoactive Substances (NPS)
dc.subjectlife-cycle(s)
dc.subjectnatural history
dc.subjectmonitoring
dc.titleFrom concept(ion) to life after death/the grave: the ‘natural’ history and life-cycle(s) of Novel Psychoactive Substances (NPS)en
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.date.embargoedUntil2018-05-01
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1002/hup.2566
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record